12:00 AM
 | 
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Verigene CYP2C19 Nucleic Acid Test regulatory update

Nanosphere said FDA granted 510(k) clearance for its Verigene CYP2C19 Nucleic Acid Test as an aid for clinicians to determine therapeutic strategy for drugs...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >